Literature DB >> 7911094

Perinatal outcome in pregnancies complicated by pulmonary tuberculosis.

N Jana1, K Vasishta, S K Jindal, B Khunnu, K Ghosh.   

Abstract

OBJECTIVES: To assess the perinatal outcome of pregnancies complicated by active pulmonary tuberculosis.
METHODS: The perinatal outcome of 79 gravidas with pulmonary tuberculosis was compared with that of 316 normal gravidas of similar age, parity and socioeconomic status.
RESULTS: The mean birthweight of infants (2649 g) born to tuberculous mothers was 215 g less than that of control group (P < 0.001). Pulmonary tuberculosis was associated with an approximate 2-fold increase in prematurity (22.8% vs. 11.1%, P < 0.01), small for gestational age (20.2% vs. 7.9%, P < 0.005) and low birthweight neonates (34.2% vs. 16.5%, P < 0.001), and 6-fold increase in perinatal deaths (10.1% vs. 1.6%, P < 0.001). The adverse perinatal outcome was pronounced in cases with late diagnosis, incomplete and irregular treatment, and advanced pulmonary lesions.
CONCLUSIONS: Maternal tuberculosis is a high-risk perinatal condition. The study emphasizes the need for early diagnosis and treatment of tuberculosis, preferably before pregnancy, regular medical supervision and good perinatal care for tuberculous mothers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911094     DOI: 10.1016/0020-7292(94)90064-7

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  29 in total

Review 1.  Tuberculosis in pregnancy and the puerperium.

Authors:  P Ormerod
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

2.  Latent tuberculosis among pregnant mothers in a resource poor setting in Northern Tanzania: a cross-sectional study.

Authors:  Faheem G Sheriff; Karim P Manji; Mohamed P Manji; Mohamedsuhel M Chagani; Rose M Mpembeni; Ahmed M Jusabani; Zaheerabbas R Alwani; Taha S Karimjee
Journal:  BMC Infect Dis       Date:  2010-03-07       Impact factor: 3.090

Review 3.  Is there a connection between gestational diabetes mellitus, human immunodeficiency virus infection, and tuberculosis?

Authors:  M Alexander; A Gupta; J S Mathad
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

Review 4.  Quality of life in tuberculosis: a review of the English language literature.

Authors:  Betty Chang; Albert W Wu; Nadia N Hansel; Gregory B Diette
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

5.  Challenges of Childhood TB/HIV Management in Malawi.

Authors:  G Poerksen; Pn Kazembe; Sm Graham
Journal:  Malawi Med J       Date:  2007-12       Impact factor: 0.875

6.  Pharmacokinetics of isoniazid in low-birth-weight and premature infants.

Authors:  A Bekker; H S Schaaf; H I Seifart; H R Draper; C J Werely; M F Cotton; A C Hesseling
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

7.  Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru.

Authors:  Eda Palacios; Rebecca Dallman; Maribel Muñoz; Rocio Hurtado; Katiuska Chalco; Dalia Guerra; Lorena Mestanza; Karim Llaro; Cesar Bonilla; Peter Drobac; Jaime Bayona; Melissa Lygizos; Holly Anger; Sonya Shin
Journal:  Clin Infect Dis       Date:  2009-05-15       Impact factor: 9.079

Review 8.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps.

Authors:  Jyoti S Mathad; Amita Gupta
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

9.  Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study.

Authors:  Nicole Salazar-Austin; Jennifer Hoffmann; Silvia Cohn; Fildah Mashabela; Ziyaad Waja; Sanjay Lala; Christopher Hoffmann; Kelly E Dooley; Richard E Chaisson; Neil Martinson
Journal:  Clin Infect Dis       Date:  2018-03-05       Impact factor: 9.079

10.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.